FDA Meeting for Tanruprubart (formerly ANX005), the First Potential Targeted Therapy for GBS, Scheduled for Second Quarter 2025 Ahead of Planned BLA Submission Open-Label Tanruprubart FORWARD Study De ...

The lone May evaluation period is just a few days away. Beginning Friday at 8 a.m. through Sunday at 4 p.m., college coaches ...

By Benjamin Mensah Accra, May 12, GNA-Rotary International President Elect Mário César Martins de Camargo has challenged ...